drugset

drugset / Trial / NCT01507337

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

NCT01507337 ↗

Phase 1 Completed 32 enrolled Novo Nordisk A/S

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare the exposure of liraglutide in young versus elderly healthy subjects.

Timeline

Start: 2004-04
Primary completion: 2004-06
Completion: 2004-06

Publications

Results Damholt B, Golor G, Wierich W, Pedersen P, Ekblom M, Zdravkovic M. An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide. J Clin Pharmacol. 2006 Jun;46(6):635-41. doi: 10.1177/0091270006288215.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Liraglutide	Peptide	1 mg	Subcutaneous

Indications